Sunday, April 3, 2016

Biotech Stocks Facing FDA Decision In April

The journey of new drugs from lab to market is a long one. Some drugs pass the FDA muster easily while some face a host of hurdles before getting the official stamp of approval. The following are the list of companies awaiting word from the FDA this month.

from RTT - Biotech http://ift.tt/2323WDp
via IFTTT

No comments:

Post a Comment